Results 81 to 90 of about 449,349 (233)
Multimodality Imaging Agents with PET as the Fundamental Pillar.
Angewandte Chemie, 2019 Positron emission tomography (PET) provides quantitative information in vivo with ultra-high sensitivity but is limited by its relatively low spatial resolution.
Dalong Ni, Emily B. Ehlerding, W. Cai
semanticscholar +1 more source
Anesthesia in PET/MRI. Challenges for the Anesthesiologist: A Narrative Review
Journal of Neuroanaesthesiology and Critical CarePositron emission tomography magnetic resonance imaging (PET/MRI) is an advanced imaging modality that combines metabolic information obtained from PET with anatomical and functional details obtained from MRI.
Sudhir Venkataramaiah +2 more
doaj +1 more source
In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol [PDF]
EJNMMI Research, 2014 The purpose of the study was to evaluate the applicability of (18) F-labelled amyloid imaging positron emission tomography (PET) agent [ (18) F]flutemetamol to detect changes in brain beta-amyloid (Aβ) deposition in vivo in APP23, Tg2576 and APPswe-PS1dE9 mouse models of Alzheimer's disease.
Snellman, Anniina +9 more
openaire +4 more sources
Inorganic Chemistry, 2017 Positron emission tomography (PET) is emerging as one of the most important diagnostic tools for brain imaging, yet the most commonly used radioisotopes in PET imaging, 11C and 18F, have short half-lives, and their usage is thus somewhat limited.
A. Sharma +4 more
semanticscholar +1 more source
Immunoscintigraphy for therapy decision making and follow-up of biological therapies [PDF]
, 2016 With the availability of new biological therapies there is the need of more accurate diagnostic tools to noninvasively assess the presence of their targets.
Auletta, S. +6 more
core +2 more sources
Therapeutic Advances in Neurological Disorders, 2018 Imaging plays several key roles in managing brain tumors, including diagnosis, prognosis, and treatment response assessment. Ongoing challenges remain as new therapies emerge and there are urgent needs to find accurate and clinically feasible methods to ...
Hari Nandu +2 more
doaj +1 more source
Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging
Pharmaceuticals, 2018 Aptamers are short single-stranded DNA or RNA oligonucleotide ligand molecules with a unique three-dimensional shape, capable of binding to a defined molecular target with high affinity and specificity. Since their discovery, aptamers have been developed
Leila Hassanzadeh +2 more
doaj +1 more source
New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities [PDF]
, 2015 CXCR4 is a target of growing interest for the development of new therapeutic drugs and imaging agents as its role in multiple disease states has been demonstrated.
Archibald, Stephen J. +14 more
core +2 more sources